A Role for Brain Cyclooxygenase-2 and Prostaglandin-E2 in Migraine: Effects of Nitroglycerin

International Review of Neurobiology

Volumn 82, Issue , 2007, Pages 373-382

  Tassorelli, Cristina ^a,b   Greco, Rosaria ^a   Armentero, Marie Therèse ^a   Blandini, Fabio ^a   Sandrini, Giorgio ^a,b   Nappi, Giuseppe ^a,b,c  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b Section of Pavia   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GLYCERYL TRINITRATE; PROSTAGLANDIN E2; VASODILATOR AGENT;

ANIMAL; BIOSYNTHESIS; BRAIN; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; MALE; MIGRAINE; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVIEW; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; MIGRAINE DISORDERS; NITROGLYCERIN; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 34547367445     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(07)82020-4     Document Type: Review

References (40)

1. Bergerot A., Holland P.R., Akerman S., Bartsch T., Ahn A.H., Maassenvandenbrink A., Reuter U., Tassorelli C., Schoenen J., Mitsikostas D.D., van den Maagdenberg A.M., and Goadsby P.J. Animal models of migraine: Looking at the component parts of a complex disorder. Eur. J. Neurosci. 24 (2006) 1517-1534
2. Bito L.Z., Davson H., and Hollingsworth J.R. Facilitated transport of prostaglandins across the across the blood-cerebrospinal fluid and blood-brain barriers. J. Physiol. 256 (1976) 273-285
3. Breder C.D., Dewitt D., and Kraig R.P. Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol. 355 (1995) 296-315
4. Ebersberger A., Ringkamp M., Reeh P.W., and Handwerker H.O. Recordings from brain stem neurons responding to chemical stimulation of subarachnoid space. J. Neurophysiol. 77 (1997) 3122-3133
5. Ebersberger A., Averbeck B., Messlinger K., and Reeh P.W. Release of substance P, calcitonin gene- related peptide and prostaglandin E2 from dura mater encephali following electrical chemical stimulation in vitro. Neuroscience 89 (1999) 901-907
6. Engblom D., Satha S., Engstrom L., Westman M., Audloy L.P., Jakobsson P.J., and Blomqvist A. Microsomial prostaglandin E synthase-1 is central switch during immune-induced pyresis. Nat. Neurosci. 6 (2003) 1137-1138
7. Greco R., Tassorelli C., Cappelletti D., Sandrini G., and Nappi G. Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine. Neurotoxicology 26 (2005) 795-800
8. Guay J., Bateman K., Gordon R., Mancini J., and Riendeau D. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in central nervous system associated with the induction of microsomial PGE2 synthase-1. J. Biol. Chem. 279 (2004) 24866-24872
9. Heitsch H. Bradykinin B2 receptor as a potential therapeutic target. Drug News Perspect. 13 (2000) 213-225
10. Hofacker A., Coste O., Nguyen H.V., Marian C., Scholich K., and Geisslinger G. Downregulation of cytosolic prostaglandin E2 synthase results in decreased nociceptive behavior in rats. J. Neurosci. 25 (2005) 9005-9009
11. Hosoi M., Oka T., and Hori T. Prostaglandin E receptor EP3 subtype is involved in thermal hyperalgesia through its actions in the preoptic hypothalamus and the diagonal band of Broca in rats. Pain 71 (1997) 303-311
12. Hosoi M., Oka T., and Aou S. Pain modulatory actions of cytokines and prostaglandin E2 in the brain. Ann. N. Y. Acad. Sci. 840 (1998) 269-281
13. Jones S.A., Adamson S.L., Engelberts D., Bishai I., Norton J., and Coceani F. PGE2 in the perinatal brain: Local synthesis and transfer across the blood brain barrier. J. Lipid Mediat. 6 (1993) 487-492
14. Kudrow D., Thomas H.M., Ruoff G., Ishkanian G., Sands G., Le V.H., and Brown M.T. Valdecoxib for treatment af single, acute, moderate to severe migraine headache. Headache 45 (2005) 1151-1162
15. Lee K.M., Kang B.S., Lee H.L., Son S.J., Hwang S.H., Kim D.S., Park J.S., and Cho H.J. Spinal NF-kB activation induces COX-2 upregulation and contribute to inflammatory pain hypersensitivity. Eur. J. Neurosci. 19 (2004) 3375-3381
16. Mollace V., Muscoli C., Masine E., Cuzzocrea S., and Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol. Rev. 57 (2005) 217-252
17. Olesen J., Iversen H.K., and Thomsen L. Nitric oxide supersensitivity: A possible molecular mechanism of migraine pain. Neuroreport 4 (1993) 1027-1030
18. Parantainen J., Vapaatalo H., and Hokkanen E. Relevance of prostaglandins in migraine. Cephalalgia 2 (1985) 93-97
19. Pardutz A., Krizbai I., Multon S., Vecsei L., and Schoenen J. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport 11 (2000) 3071-3075
20. Pardutz A., Szatmari E., Vecsei L., and Schoenen J. Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan. Cephalalgia 24 (2004) 439-445
21. Reuter U., Bolay H., Jansen-Olesen I., Chiarugi A., Sanchez del Rio M., Letourneau R., Theoharides T.C., Waeber C., and Moskowitz M.A. Delayed inflammation in rat meninges: Implications for migraine pathophysiology. Brain 12 (2001) 2490-2502
22. Riendeau D., Percival M.D., Boyce S., Brideau C., Charleston S., Cromlish W., Hethier D., Evans J., Falqueyret J.P., Ford-Hutchinson A.W., Gordon R., Greig G., et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol. 121 (1997) 105-117
23. Rivest S. What is cellular source of prostaglandins in the brain in response to systemic inflammation? Fact and controversies. Mol. Psychiatry 4 (1999) 501-507
24. Sakaue G., Shimaoka M., Fukuoka T., Hiroi T., Inoue T., Hashimoto N., Sakaguchi T., Sawa Y., Morishita R., Kiyono H., Noguchi K., and Mahimo M. NF-kappa B decoy suppress cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 12 (2001) 2079-2084
25. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90 (1993) 7240-7244
26. Sandrini G., Tassorelli C., Proietti Cecchini A., Alfonsi E., and Nappi G. Effects of nimesulide on nitric oxide-induced hyperalgesia in humans - A neurophysiological study. Eur. J. Pharmacol. 450 (2002) 259-262
27. Sarchielli P., Alberti A., Codini M., Floridi A., and Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 20 (2000) 907-918
28. Silberstein S., Tepper S., Brandes J., Diamond M., Goldstein J., Winner P., Venkatraman S., Vrijens F., Malbecq W., Lines C., Visser W.H., Reines S., et al. Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine. Neurology 62 (2004) 1552-1557
29. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., Talley J.J., MasferreR J.L., Seibert K., and Isakson P.C. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA 95 (1998) 13313-13318
30. Stirparo G., Zicari A., Favilla M., Lipari M., and Martelletti P. Linked activation of nitric oxide synthase and cyclooxygenase in peripheral monocytes of asymptomatic migraine without aura patients. Cephalalgia 20 (2000) 100-106
31. Strassman A.M., Raymond S.A., and Burstein R. Sensitization of meingeal sensory neurons and origin of headaches. Nature 384 (1996) 60-564
32. Tassorelli C., and Joseph S.A. Systemic nitroglycerin induces Fos-ir in brainstem and forebrain structures of the rat. Brain Res. 682 (1995) 167-178
33. Tassorelli C., Joseph S.A., Buzzi G., and Nappi G. The effect on the central nervous system of nitroglycerin-Putative mechanisms and mediators. Progr. Neurobiol 57 (1999) 607-624
34. Tassorelli C., Greco R., Sandrini G., and Nappi G. Central components of the analgesic/antihyperalgesic effect of nimesulide: Studies in animal models of pain and hyperalgesia. Drugs 63 (2003) 9-22
35. Tassorelli C., Greco R., Wang D., Morelli G., and Nappi G. Nitroglycerin induces Hyperalgesia in Rats: A Time-Course Study. Eur. J. Pharmacol. 464 (2003) 159-162
36. Tassorelli C., Greco R., Morazzoni P., Riva A., Sandrini G., and Nappi G. Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: Studies in an animal model of migraine. Cephalalgia 25 (2005) 612-621
37. Tassorelli C., Greco R., Wang D., Sandrini G., and Nappi G. Prostaglandins, glutamate and nitric oxide synthase mediate nitroglycerin-induced hyperalgesia in the formalin test. Eur. J. Pharmacol. 534 (2006) 103-107
38. Tuca J.O., Planas J.M., and Parellada P.P. Increase in PGE2 and TXA2 in the saliva of common migraine patients Action of calcium channel blockers. Headache 29 (1989) 498-501
39. Turrin N.P., and Rivest S. Unraveling the Molecular Details Involved in the Intimate Link between the Immune and Neuroendocrine Systems. Exp. Biol. Med. 229 (2004) 996-1006
40. Vanegas H., and Schaible H.G. Prostaglandin and cyclooxygenase in the spinal cord. Prog. Neurobiol. 64 (2001) 327-363